IE 11 is not supported. For an optimal experience visit our site on another browser.

MAKO Surgical Corp. to Present at the Barclays Capital 2011 Global Healthcare Conference

/ Source: GlobeNewswire

FT. LAUDERDALE, Fla., March 4, 2011 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer, will present at the Barclays Capital 2011 Global Healthcare Conference at the Loews Miami Beach Hotel in Miami on Wednesday, March 16, 2011 at 10:15 am ET.

A webcast will be available and may be accessed by visiting MAKO's website at under the Investor Relations section. A replay of the webcast will be available immediately after the conclusion of the presentation.

About MAKO Surgical Corp.

MAKO Surgical Corp. is a medical device company that markets both its RIO® Robotic-Arm Interactive Orthopedic system and its proprietary RESTORIS® knee implants for a minimally invasive orthopedic procedure called knee MAKOplasty®. The MAKO RIO is a surgeon-interactive tactile surgical platform that incorporates a robotic arm and patient-specific visualization technology, and prepares the knee joint for the insertion and alignment of MAKO's resurfacing RESTORIS implants through a minimal incision. The FDA-cleared and CE Marked RIO system allows surgeons to provide precise, consistently reproducible tissue-sparing, bone resurfacing for a large, yet underserved patient population suffering from early to mid-stage osteoarthritic knee disease. MAKO has an intellectual property portfolio of more than 250 owned or licensed patents and patent applications relating to the areas of robotics, haptics, computer assisted surgery and implants. Additional information can be found at .

"MAKOplasty®," "RESTORIS®" and "RIO®," as well as the "MAKO" logo, whether standing alone or in connection with the words "MAKO Surgical Corp.," are trademarks of MAKO Surgical Corp.

CONTACT: Investors: MAKO Surgical Corp. Susan M. Verde 954-628-0749 investorrelations@makosurgical.com or Westwicke Partners Mark Klausner 443-213-0500 mark.klausner@westwicke.com